Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H23N3O |
| Molecular Weight | 285.384 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1CCC(CC1)C2=NC(=NO2)C3=CC=NC=C3
InChI
InChIKey=OAVLEYPTWABFLF-UHFFFAOYSA-N
InChI=1S/C17H23N3O/c1-2-3-4-13-5-7-15(8-6-13)17-19-16(20-21-17)14-9-11-18-12-10-14/h9-13,15H,2-8H2,1H3
| Molecular Formula | C17H23N3O |
| Molecular Weight | 285.384 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16517404Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24323890
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517404
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24323890
PSN375963 is agonist of GPR119 receptor. Treatment of mice islet cells with PSN375963 stimulated insuline resistance.
Originator
Sources: http://www.google.tl/patents/WO2005061489A1
Curator's Comment: Aquired by OSI Pharmaceuticals
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q8TDV5 Gene ID: 139760.0 Gene Symbol: GPR119 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517404 |
8.4 µM [EC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. | 2014-04 |
|
| Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. | 2006-03 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24323890
In the model of insuline resistance, PSN375963 was administered to mice by intraperitoneal injection in combination with glucose. Dose of 0.1 umol/l/kg did not lead to statistically significant difference in AUC of plasma insulin.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16517404
Activity of PSN375963 towards GPR119 was measured in yeast fluorimetric assay and by increase of intracellular cAMP in HEK-OSGPR116 cells expressing GPR119. PSN375963 stimulates GPR119 with EC50 of 8.4 uM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:53:09 GMT 2025
by
admin
on
Wed Apr 02 09:53:09 GMT 2025
|
| Record UNII |
C9M28M425E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C9M28M425E
Created by
admin on Wed Apr 02 09:53:09 GMT 2025 , Edited by admin on Wed Apr 02 09:53:09 GMT 2025
|
PRIMARY | |||
|
2875918
Created by
admin on Wed Apr 02 09:53:09 GMT 2025 , Edited by admin on Wed Apr 02 09:53:09 GMT 2025
|
PRIMARY | |||
|
PSN-375,963
Created by
admin on Wed Apr 02 09:53:09 GMT 2025 , Edited by admin on Wed Apr 02 09:53:09 GMT 2025
|
PRIMARY | |||
|
388575-52-8
Created by
admin on Wed Apr 02 09:53:09 GMT 2025 , Edited by admin on Wed Apr 02 09:53:09 GMT 2025
|
PRIMARY | |||
|
DTXSID201028459
Created by
admin on Wed Apr 02 09:53:09 GMT 2025 , Edited by admin on Wed Apr 02 09:53:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->LIGAND |
|